PURPLE BIOTECH LTD-ADR (PPBT) Stock Price & Overview
NASDAQ:PPBT • US74638P1093
Current stock price
The current stock price of PPBT is 4.95 USD. Today PPBT is up by 1.64%. In the past month the price increased by 24.37%. In the past year, price decreased by -81.67%.
PPBT Key Statistics
- Market Cap
- 4.601M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.21
- Dividend Yield
- N/A
PPBT Stock Performance
PPBT Stock Chart
PPBT Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PPBT. When comparing the yearly performance of all stocks, PPBT is a bad performer in the overall market: 96.07% of all stocks are doing better.
PPBT Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to PPBT. PPBT may be in some trouble as it scores bad on both profitability and health.
PPBT Earnings
PPBT Forecast & Estimates
PPBT Groups
Sector & Classification
PPBT Financial Highlights
Over the last trailing twelve months PPBT reported a non-GAAP Earnings per Share(EPS) of -4.21. The EPS increased by 85.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.32% | ||
| ROE | -9.92% | ||
| Debt/Equity | 0 |
PPBT Ownership
PPBT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.31 | 869.14B | ||
| JNJ | JOHNSON & JOHNSON | 18.19 | 555.642B | ||
| MRK | MERCK & CO. INC. | 23 | 289.223B | ||
| PFE | PFIZER INC | 9.21 | 156.544B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.34 | 120.728B | ||
| ZTS | ZOETIS INC | 17.35 | 51.606B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.54 | 28.443B | ||
| VTRS | VIATRIS INC | 5.96 | 17.315B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.51 | 11.825B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.651B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.206B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.087B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.4 | 4.929B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PPBT
Company Profile
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Company Info
IPO: 1978-09-03
PURPLE BIOTECH LTD-ADR
4 Oppenheimer St., Science Park
Rehovot 7670104 IL
CEO: Gil Efron
Employees: 9
Phone: 97239333121
PURPLE BIOTECH LTD-ADR / PPBT FAQ
Can you describe the business of PURPLE BIOTECH LTD-ADR?
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
What is the current price of PPBT stock?
The current stock price of PPBT is 4.95 USD. The price increased by 1.64% in the last trading session.
What is the dividend status of PURPLE BIOTECH LTD-ADR?
PPBT does not pay a dividend.
What is the ChartMill rating of PURPLE BIOTECH LTD-ADR stock?
PPBT has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the employee count for PPBT stock?
PURPLE BIOTECH LTD-ADR (PPBT) currently has 9 employees.